Ultragenyx Pharmaceutical Inc. (RARE) is in Healthcare, Biotechnology, based in United States, listed on NasdaqGS. Market cap 1.51B USD. 52-week range 12.73 to 39.89 USD. Data as of 2026-10-09.
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Latin America, Europe, the Middle East, Africa, and the Asia-Pacific. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast growth factor 23 for the treatment of X-linked hypophosphatemia, as well as tumor-induced osteomalacia; ...